Advent International (India)
Advent International has built a local India private-equity practice around control and complex growth situations in consumer, lending, manufacturing, pharmaceuticals and technology services. Shweta Jalan leads the India team, which pairs local execution with Advent’s global operating resources.
At a glance
- Founded
- 1984
- Footprint
- Boston / Mumbai
- Stage
- Buyout
Research profile
Read the manager in sequence.
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Advent International (India) uses a buyout approach across Health, pharma, fin services, industrial.
Current evidence
Advent’s India page and portfolio story document the 2024 sale of Bharat Serums and Vaccines to Mankind after operational improvements, including a reported EBITDA uplift during ownership; the India team page remains current with Shweta Jalan identified as Managing Partner.
Strategy
Buyout
Sector focus
Health, pharma, fin services, industrial
Current signal
Advent’s India page and portfolio story document the 2024 sale of Bharat Serums and Vaccines to Mankind after operational improvements, including a reported EBITDA uplift during ownership; the India team page remains current with Shweta Jalan identified as Managing Partner.
Next step
Need this manager reviewed against your mandate?
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.